Results 141 to 150 of about 2,752 (167)

Hormonal and complimentary treatments for endometriosis: a narrative review. [PDF]

Gynecol Pelvic Med
Onishi A, Benetti-Pinto CL, Yela DA.
europepmc   +1 more source

Use of systemic hormonal contraception and risk of depression: a registry-based study from Finland. [PDF]

Eur J Epidemiol
Toffol E, Partonen T, Heikinheimo O, But A, Latvala A, Haukka J.   +5 more
europepmc   +1 more source

Venous thromboembolism in obese hormonal contraceptive users: a large national database study. [PDF]

Res Pract Thromb Haemost
Citla-Sridhar D, Rajpurkar M, Srivaths L, Bannow BS, Rosovsky RP, Sokkary N.   +5 more
europepmc   +1 more source

Post-pregnancy contraception. [PDF]

Reprod Fertil
Cooper M, Kallner HK.
europepmc   +1 more source

Exploring Antibiotic-Mediated Disruption of Enterohepatic Circulation and Combined Oral Contraceptive Efficacy: A Systematic Review. [PDF]

Womens Health Rep (New Rochelle)
Elkhoury D, Reddy N, Venkatraman D, Patel P, Montalbano M.   +4 more
europepmc   +1 more source

Excretion and metabolism of desogestrel in healthy postmenopausal women

Journal of Steroid Biochemistry and Molecular Biology, 2001
The metabolism of desogestrel (13-ethyl-11-methylene-18,19-dinor-17 alpha -pregn-4-en-20-yn-17-ol), a progestagen used in oral contraceptives and hormone replacement therapy, was studied in vivo after a single oral administration of 150 mug [C-14 ...
I M C M Rietjens
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Lipid metabolism effects with desogestrel-containing oral contraceptives

American Journal of Obstetrics and Gynecology, 1993
Ronald T Burkman, R T Burkman
exaly  

Effect of a desogestrel-containing oral contraceptive on the skin

European Journal of Contraception and Reproductive Health Care, 2000
D Whiting, H I Katz
exaly